Print this page
Rate this item
(0 votes)
Friday, 24 January 2020 14:39

EU funding to accelerate the uptake of computer simulations for drug testing and medical devices Featured

The European Commission supports the introduction of individualized computer models and simulations for the development and evaluation of drugs and medical devices.

In recent years, biomedical knowledge and bioinformatics skills have increased. It is therefore hoped that individualized computer simulations, which can be used, for example in predictive toxicology and pharmacokinetics, will lead to greater predictive power for the regulatory assessment.

However, the acceptance of such models, their implementation in the clinic and market penetration of in silico solutions depend on the trust of users, industry, investors and the competent regulatory authorities. This is where the funding program is intended to provide support.

Applications should promote the development of innovative scientific and technological computer modelling solutions for testing drugs and/or medical devices include.

The application deadline is 22 April 2020.

Further information here: